Johnson & Johnson se strinja, da bo plačal 5,5 milijarde dolarjev za poravnavo tožb za otroški prah

TheJournal.ieNeodvisenSredinaDejstva 95Objektivnost 85pred 9 dnevi

Družba Johnson & Johnson je ponudila 5,5 milijarde dolarjev za poravnavo približno 76.000 tožb, ki trdijo, da je njen talkovni prah za dojenčke povzročil raka jajčnikov ali mezoteliom.

Ocena pristranskosti (Sredina): Članek predstavlja stališče podjetja (opiranje vzročne zveze, navajanje znanstvenega pomena) in trditve tožnikov (povezovanje uporabe izdelka z rakom).

Zakaj dejstva (95): The article accurately reports the $5.5 billion settlement offer by Johnson & Johnson to resolve approximately 76,000 claims related to talc products and cancer. It includes direct quotes from the company and mentions the cessation of sales in the US and Canada in 2020. However, it incorrectly state

Zakaj objektivnost (85): The article maintains a relatively neutral tone, presenting both the company's position and the claims made by plaintiffs. However, it uses phrases like 'the firm denies' and 'lack scientific merit,' which reflect the company's stance rather than presenting alternative viewpoints equally.

RTÉ NewsDržavni / javniSredinaDejstva 90Objektivnost 85pred 9 dnevi

Družba Johnson & Johnson je napovedala poravnavo v višini 5,5 milijarde dolarjev za reševanje približno 69.000 tožb, ki trdijo, da je njen talčni prah za dojenčke povzročil raka jajčnikov.

Ocena pristranskosti (Sredina): Medtem ko vprašanje talka in zdravstvenih tveganj vključuje znanstveno in pravno razpravo, članek predstavlja informacije iz obeh strani - stališče podjetja J&J in obtožbe tožnikov - ne da bi očitno naklonil nobeni strani.

Zakaj dejstva (90): The article accurately reports the $5.5 billion settlement, noting that it covers about 69,000 cases and 99.75% of remaining talc claims. It includes relevant context such as the company's switch to cornstarch-based products in 2020 and recent court developments. The mention of a federal judge casti

Zakaj objektivnost (85): The article remains largely objective, presenting both the company's denial of wrongdoing and the plaintiffs' claims. It avoids overtly biased language while acknowledging the complexity of the legal battle and the recent judicial development.

The Irish TimesNeodvisen🔒SredinaDejstva 90Objektivnost 80pred 9 dnevi

Johnson & Johnson se je strinjal, da bo plačal do 5,5 milijarde dolarjev za poravnavo več deset tisoč ameriških tožb, ki trdijo, da njegovi izdelki na osnovi talka povzročajo raka jajčnikov. To poravnava zajema približno 76.000 zahtevkov, vključno s tistimi na zveznih in državnih sodiščih, in označuje konec desetletne pravne bitke.

Ocena pristranskosti (Sredina): Članek predstavlja uravnoteženo poročilo o obeh straneh pravnega spora, citira izjave vodilnih delavcev podjetja Johnson & Johnson, ki so zavrnili trditve kot "brezpredmetne", in odvetnike tožnikov, ki so poravnavo opisali kot ugodno.

Zakaj dejstva (90): The article provides accurate details about the $5.5 billion settlement covering about 76,000 claims and includes direct quotes from Johnson & Johnson's vice president of litigation. It also mentions the company's previous settlements regarding asbestos-related claims. However, it slightly underesti

Zakaj objektivnost (80): The article presents the facts neutrally, quoting both the company and the plaintiffs' attorneys. However, it leans slightly toward the company's perspective by emphasizing their confidence in prevailing in further litigation, which could subtly influence reader perception.

Irish IndependentNeodvisenSredinaDejstva 85Objektivnost 75pred 9 dnevi

Družba Johnson & Johnson je napovedala načrt v višini 5,5 milijarde dolarjev, katerega cilj je rešiti tekoče pravne primere, povezane z rakom jajčnikov, povezanimi z njenimi izdelki na osnovi talka. Predlog je del prizadevanj za poravnavo številnih tožb, ki trdijo, da so talčni prašiči družbe povzročili raka.

Ocena pristranskosti (Sredina): Članek predstavlja dejanske informacije o načrtu poravnave podjetja, ne da bi odkrito podprl ali kritiziral dejanja podjetja.

Zakaj dejstva (85): The headline accurately reflects the $5.5 billion settlement offer by Johnson & Johnson. However, the article lacks detailed specifics such as the number of claims covered or the timeline of events. This makes it less comprehensive compared to other sources that provide more precise figures and cont

Zakaj objektivnost (75): The article is brief and does not present any clear bias, but it focuses primarily on the company's actions without providing much context on the plaintiffs' perspective. The lack of depth may lead to a one-sided understanding of the situation.